Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report
Oncology Letters - Greece
doi 10.3892/ol.2012.647
Full Text
Open PDFAbstract
Available in full text
Date
March 16, 2012
Authors
Publisher
Spandidos Publications